Utilization and Expenditure of Vaginal Estrogen in the US Among Medicare Part D Beneficiaries

Friday, October 6, 2023

8:04 AM – 8:08 AM US PST

Location: B113-116

Click to View Image
Image Label: Figure 1: Total claims for vaginal estrogen for all provider types, per Medicare Part D spending database, 2016-2020

Click to View Image
Image Label: Figure 2: Number of vaginal estrogen claims per OB/GYN physician per Medicare Part D prescriber database, 2016-2020

Presenting Author(s)

Alexandra Tabakin, MD

Fellow
Division of Female Pelvic Medicine and Reconstructive Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Great Neck, New York, United States

PDF

Co-Author(s)

WL

Wai Lee, MD

Urologist
Smith Institute for Urology
Lake Success, New York, United States
Harvey Winkler, MD, MBA

System Chief Urogynecology
Northwell Health
Great Neck, New York, United States
DS

Dara F. Shalom, MD, FACOG, FPMRS (she/her/hers)

Associate Chief of Urogynecology, Fellowship Program Director
Northwell Health
Great Neck, New York, United States

Disclosure(s):

Alexandra Tabakin, MD: No financial relationships to disclose

Wai Lee, MD: No financial relationships to disclose

Harvey Winkler, MD, MBA: Boston Scientific: Consultant/Advisory Board (Ongoing); Coloplast: Clinical Evalution Committe member (Ongoing); ConTipi: Consultant/Advisory Board (Ongoing); Johnson and Johnson: Expert Witness (Ongoing); Kimberly Clark: Consultant/Advisory Board (Ongoing)

Dara F. Shalom, MD, FACOG, FPMRS: Boston scientific: Consultant/Advisory Board (Ongoing)

Do you prescribe vaginal estrogen and wish other medical professionals would too? Learn about recent trends in vaginal estrogen prescribing and expenditures in a large database of Medicare beneficiaries. The findings may surprise you!